Effingham Equity

Warning LetterOpen

United StatesFEI 1480885Issued Sep 20, 2022Division of Human and Animal Food Operations East VI

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 1480885.

Violations0

Issue DateSep 20, 2022

Product TypeAnimal & Veterinary

StatusOpen

Letter Details

Firm: Effingham Equity
Location: United States
FEI Number: 1480885
Country: United States
Issue Date: September 20, 2022
Issuing Office: Division of Human and Animal Food Operations East VI
Product Type: Animal & Veterinary
Status: Open

Summary

Based on limited metadata, Effingham Equity received an FDA Warning Letter on September 20, 2022, regarding animal and veterinary products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's animal and veterinary product regulatory authority, though the specific issuing office is not identified in this metadata. To understand the particular compliance issues cited, the complete Warning Letter would need to be reviewed.

Effingham Equity FDA Warning Letter, September 20, 2022